Loeb & Loeb LLP is proud to be a sponsor of American Conference Institute's (ACI) 2nd West Coast Edition Paragraph IV Disputes: Expert Insights on Hatch-Waxman Litigation Strategies for Brand Names and Generics Conference, where partner Mark Waddell will Co-chair the conference.
From the conference website:
The must-attend event for litigators from brand name and generic companies to share insights into increasingly high-stakes and complicated Hatch-Waxman litigation
At American Conference Institute’s 2nd Annual West Coast edition of its acclaimed Paragraph IV Disputes conference, an experienced faculty of renowned litigators and judges will guide you through every stage of a Paragraph IV challenge to help you formulate the offensive moves and defensive plays for the next round in the no-holds barred fight for pharmaceutical product market share. Additionally, in the wake of major developments in pay-for-delay, learn what the Federal Trade Commission deems foul and fair in the settlement of Paragraph IV disputes in order to draft and structure a settlement that will receive FTC approval.
At this in-depth strategy session on the nuances of PIV litigation, our West Coast delegates will gain the tools to advance a novel claim or defense to protect patents and market share based on the expertise of trial leading patent counsel from generic and branded companies – and the judges – who have experienced the intricacies of Hatch Waxman litigation first hand. Featuring an up-to-the-minute analysis of the latest game-changing case law developments regarding inequitable conduct, inducement of infringement and the standard of invalidity, this conference will give our attendees the tools and litigation strategies to help both brand name and generic companies protect market share and ultimately profits.
For more information, including how to register, please visit American Conference Institute's website.